HomeTrading IdeasWeekly Market Outlook: Key...

Weekly Market Outlook: Key Moves in Gold, EUR/USD, and USD/JPY

Global financial markets are entering a crucial week loaded with high-impact macroeconomic developments and policy events that could redefine short-term trends across currencies, commodities, and equities. Central banks once again take the spotlight, with both the Reserve Bank of Australia (RBA) and the Reserve Bank of New Zealand (RBNZ) preparing policy decisions.

However, the most anticipated item remains the release of the , which could offer critical insights into the timing and pace of the Federal Reserve’s long-awaited pivot toward easing.

Complicating the macro picture is the revival of the Trump-era tax debate, with mounting speculation that former President Donald Trump, should he regain office, could reintroduce or expand tax reforms aimed at cutting corporate taxes further. This potential policy shift is already rippling through market sentiment.

Equity markets have priced in improved after-tax earnings, while the has found some support on expectations of a growth-friendly, pro-business environment that could delay or soften Fed rate cuts. However, this optimism is tempered by fiscal sustainability concerns, with analysts warning that deeper tax cuts could exacerbate the U.S. deficit and elevate Treasury yields, potentially tightening financial conditions again.

Central Bank Highlights This Week

Tuesday, July 8:

The RBA is expected to cut its benchmark rate from 3.85% to 3.60%, marking its third cut this year, as it grapples with sluggish GDP growth, weaker exports, and fading consumer demand. Australian inflation has also shown signs of cooling, opening the door for further policy easing.

Wednesday, July 9:

The RBNZ meets under similar conditions, although inflation in New Zealand remains stickier than in Australia. A pause is possible, but dovish language is expected, particularly in light of global deflationary headwinds. Later that day, all eyes will be on the FOMC minutes, which may confirm whether Fed officials are leaning toward a September rate cut.

Markets currently price in a 75% chance of a cut by that meeting, but any sign of hesitation, particularly in light of political uncertainty or inflation risks, could spark repricing.

Thursday and Friday:

Jobless claims in the U.S. and industrial production figures from the eurozone, UK, and Canada will help refine the global growth outlook. Additionally, comments from Fed members like Waller and Daly could either reinforce or challenge the market’s dovish bias.

EUR/USD Holds Steady Ahead of Fed Minutes

The euro is holding ground above the 1.17 level, supported by improved PMI figures in Germany and France, as well as rising investor confidence that the European Central Bank (ECB) will maintain a data-dependent stance rather than pre-committing to easing. The Fed’s cautious tone, reflected in recent speeches, has contributed to narrowing rate differentials, weakening the dollar’s advantage.

Complicating the outlook is the Trump tax narrative: should fiscal stimulus return to the U.S. under a Republican-led government, the dollar could regain strength, especially if growth expectations outweigh concerns about debt.

Technically, is showing continued bullish strength, trading above its 20-, 50-, and 100-day EMAs and approaching the upper Bollinger Band. MACD remains positive, while the Stochastic RSI signals mild overbought conditions.

Support levels include 1.1640, 1.1460, and 1.1379, while resistance zones are at 1.1746, 1.1872, and 1.2000. And while the Outlook is moderately bullish, Pullbacks remain buying opportunities unless price closes below 1.1460.

Gold Consolidates Amid Rate Cut Bets

prices are consolidating around $3,300, caught between expectations and rising political risk premiums. While softer inflation and slower job growth support demand for the metal, potential Trump-driven tax reforms and the resulting boost in real yields could pose headwinds. Also, relevant are the ballooning U.S. debt and geopolitical uncertainty, factors that keep gold attractive as a hedge against policy missteps and long-term currency debasement.

Technically, gold remains in a medium-term uptrend, supported by the 20-, 50-, and 100-day EMAs. The MACD remains slightly bearish, while Bollinger Bands are narrowing, typically a sign of a breakout brewing. Stochastic RSI near 50 suggests neutral momentum. Support lies at 3297, 3277, and 3186. Resistance levels are 3333, 3348, and 3418.

The Outlook is Neutral-to-bullish bias, with caution below 3,277. Positioning remains defensive ahead of U.S. inflation data and Fed minutes.
 Gold Price Chart

USD/JPY on the Brink of a Breakout

The yen is in focus this week as the dollar/yen pair approaches critical resistance, with investors weighing Bank of Japan’s ultra-loose policy against possible Fed easing. Trump’s tax narrative adds another layer: if markets begin pricing in a more hawkish fiscal environment, U.S. yields may stay elevated, supporting .

So far, the pair is hovering just below the 146.25 resistance level (100-day EMA), after recently reclaiming the 20- and 50-day averages. MACD is close to a bullish crossover and Bollinger Bands are tight, signaling a pending breakout.

Support levels are at 144.60, 143.26, and 141.80. Resistance levels include 145.15, 146.20, and 148.00.USD/JPY Chart

Most Popular

More from Author

Read Now

Can Trump’s ‘Run It Hot’ Plan Trap the Fed and Jolt the Bond Market?

Trump wants to run the economy hot to out of debt. So, what are the implications for markets? The Trump administration’s plan for the next 12 months could look like the following: 1) More tariffs: threaten big tariffs by Aug 1st, and ‘’close deals’’ with higher tariff rates before...

Midyear Market Check: Bulls in Control, but Valuations and Sentiment Flash Caution

Don’t look now fans, but the first half of 2025 is in the books. As we embark on the second half of the year, I thought it would be a good idea to review the key areas of analysis for the stock market.Such a review includes my...

Trump’s New Tariffs Shake Markets as Yen and ETFs Slide – iShares MSCI Japan Index Fund (ARCA:EWJ), iShares MSCI Malaysia Index Fund (ARCA:EWM)

The U.S. dollar is notching its strongest one-day gain against the Japanese yen in nearly two months as traders react to President Donald Trump's sweeping new tariffs targeting multiple U.S. trading partners.Starting Aug. 1, all goods imported from Japan and other Asian trading partners will face a...

The Bull Market Is Alive and Well

The bull market is alive and well, even amid widespread talk of the “death of U.S. exceptionalism.” Early 2025 saw a sharp shift in investor sentiment. Concerns over erratic trade policy, soaring debt, and weakening pressure challenged America’s long-standing market dominance. Markets fell sharply in April...

Why Is Jasper Therapeutics Stock Falling On Monday? – Jasper Therapeutics (NASDAQ:JSPR)

Jasper Therapeutics, Inc. JSPR stock is experiencing a steep decline on Monday, plummeting by nearly 55%. This significant drop is accompanied by an exceptionally high trading volume of 9.9 million shares, vastly exceeding its average daily volume of 251.9K, according to data from Benzinga Pro.What Happened?The company...

Stocks Wobble as Trump Resurrects Tariff Threats Ahead of July 9 Deadline

Market participants were expecting an upbeat start to the week on the hope that trade deals might finally be announced as the Trump administration deadline of July 9 approaches. However, President Trump adopted a confrontational stance once more by announcing that the US will begin issuing tariff...

CAD/JPY Ready to Continue Rising Ahead of Employment Change and Unemployment Rate

For three months since April, the currency has shown strength against the . although at the moment the price still cannot break the small resistance area on the H4 timeframe. but it is expected that the fundamental impulses can move the market more significantlyFigure 1. CAD/JPY...

What’s Going On With Hims & Hers Health Stock On Monday? – Hims & Hers Health (NYSE:HIMS)

Hims & Hers Health, Inc. HIMS is currently experiencing a decline in its stock price, trading lower on Monday. The company’s stock has plummeted approximately 18% over the past month, reflecting recent challenges.A significant development contributing to this decline occurred in June 2025, when Novo Nordisk A/S...

Why Is Cogent Biosciences Stock Trading Higher On Monday? – Cogent Biosciences (NASDAQ:COGT)

Cogent Biosciences, Inc.‘s COGT bezuclastinib showed meaningful clinical benefit for patients with non-advanced systemic mastocytosis, a rare and debilitating immune disorder. With statistically significant improvements across all endpoints—including symptom reduction and biomarkers of mast cell activity—the data support the company's plan to file for Food and Drug Administration...

3 Bullish Setups to Watch in July Amid Seasonal Tailwinds

As the second half of the year begins, several bullish setups are emerging—each supported by seasonal patterns and historical data. is approaching multi-year highs following a strong June, while technical signals in the broader market and semiconductor sector point to continued momentum. Meanwhile, recent policy developments may...

The Energy Report: Listen to What OPEC Says

prices are shaking off a larger-than-expected OPEC production increase as the precious metals get hit by a ton of bricks after President Trump posted about new tariffs on BRIC Nations on his Truth Social account. Yet despite the talk about OPEC wanting to maintain its market share,...

Why Is KalVista Pharmaceuticals Stock Soaring On Monday? – KalVista Pharma (NASDAQ:KALV)

The U.S. Food and Drug Administration (FDA) on Monday approved KalVista Pharmaceuticals Inc.’s KALV Ekterly (sebetralstat) for acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged 12 years and older.Ekterly is the first and only oral on-demand treatment for HAE. HAE is characterized by recurrent...